Böhmer FD - Search Results

1

Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation.

Buchwald M, Pietschmann K, Müller JP, Böhmer FD, Heinzel T, Krämer OH. Buchwald M, et al. Among authors: bohmer fd. Leukemia. 2010 Aug;24(8):1412-21. doi: 10.1038/leu.2010.114. Epub 2010 May 27. Leukemia. 2010. PMID: 20508617

2

A phosphorylation-acetylation switch regulates STAT1 signaling.

Krämer OH, Knauer SK, Greiner G, Jandt E, Reichardt S, Gührs KH, Stauber RH, Böhmer FD, Heinzel T. Krämer OH, et al. Among authors: bohmer fd. Genes Dev. 2009 Jan 15;23(2):223-35. doi: 10.1101/gad.479209. Genes Dev. 2009. PMID: 19171783 Free PMC article.

3

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia.

Sellmer A, Pilsl B, Beyer M, Pongratz H, Wirth L, Elz S, Dove S, Henninger SJ, Spiekermann K, Polzer H, Klaeger S, Kuster B, Böhmer FD, Fiebig HH, Krämer OH, Mahboobi S. Sellmer A, et al. Among authors: bohmer fd. Eur J Med Chem. 2020 May 1;193:112232. doi: 10.1016/j.ejmech.2020.112232. Epub 2020 Mar 13. Eur J Med Chem. 2020. PMID: 32199135

4

Features of Ras activation by a mislocalized oncogenic tyrosine kinase: FLT3 ITD signals through K-Ras at the plasma membrane of acute myeloid leukemia cells.

Köthe S, Müller JP, Böhmer SA, Tschongov T, Fricke M, Koch S, Thiede C, Requardt RP, Rubio I, Böhmer FD. Köthe S, et al. Among authors: bohmer sa, bohmer fd. J Cell Sci. 2013 Oct 15;126(Pt 20):4746-55. doi: 10.1242/jcs.131789. Epub 2013 Aug 13. J Cell Sci. 2013. PMID: 23943874

5

ATRA can enhance apoptosis that is induced by Flt3 tyrosine kinase inhibition in Flt3-ITD positive cells.

Scholl S, Müller R, Clement JH, Loncarevic IF, Böhmer FD, Höffken K. Scholl S, et al. Among authors: bohmer fd. Leuk Res. 2006 May;30(5):633-42. doi: 10.1016/j.leukres.2005.10.005. Epub 2006 Feb 13. Leuk Res. 2006. PMID: 16473406

6

Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.

Kresinsky A, Schnöder TM, Jacobsen ID, Rauner M, Hofbauer LC, Ast V, König R, Hoffmann B, Svensson CM, Figge MT, Hilger I, Heidel FH, Böhmer FD, Müller JP. Kresinsky A, et al. Among authors: bohmer fd. Oncogene. 2019 Jun;38(24):4773-4787. doi: 10.1038/s41388-019-0757-y. Epub 2019 Feb 28. Oncogene. 2019. PMID: 30820040

7

Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.

Tse KF, Allebach J, Levis M, Smith BD, Bohmer FD, Small D. Tse KF, et al. Among authors: bohmer fd. Leukemia. 2002 Oct;16(10):2027-36. doi: 10.1038/sj.leu.2402674. Leukemia. 2002. PMID: 12357354

8

Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor.

Tse KF, Novelli E, Civin CI, Bohmer FD, Small D. Tse KF, et al. Among authors: bohmer fd. Leukemia. 2001 Jul;15(7):1001-10. doi: 10.1038/sj.leu.2402199. Leukemia. 2001. PMID: 11455967

9

Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.

Scholl S, Kirsch C, Böhmer FD, Klinger R. Scholl S, et al. Among authors: bohmer fd. J Cancer Res Clin Oncol. 2004 Dec;130(12):711-8. doi: 10.1007/s00432-004-0602-7. Epub 2004 Aug 31. J Cancer Res Clin Oncol. 2004. PMID: 15340843

10

A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571.

Böhmer FD, Karagyozov L, Uecker A, Serve H, Botzki A, Mahboobi S, Dove S. Böhmer FD, et al. J Biol Chem. 2003 Feb 14;278(7):5148-55. doi: 10.1074/jbc.M209861200. Epub 2002 Nov 14. J Biol Chem. 2003. PMID: 12435730 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters